Bulk Manufacturer of Controlled Substances Application: Johnson Matthey Pharmaceutical Materials Inc., 71465 [2019-27951]
Download as PDF
<![CDATA[
71465
Federal Register / Vol. 84, No. 248 / Friday, December 27, 2019 / Notices
Firearms and Explosives (ATF), will
submit the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
The proposed information
collection was previously published in
the Federal Register, on October 24,
2019, allowing for a 60-day comment
period. Comments are encouraged and
will be accepted for an additional 30
days until January 27, 2020.
DATES:
If
you have additional comments
regarding the estimated public burden
or associated response time,
suggestions, or need a copy of the
proposed information collection
instrument with instructions, or
additional information, please contact:
Renee Reid, FO/ESB—Mailstop (7.E–
401), either by mail at 99 New York
Ave. NE, Washington DC, 20226, by
email at Renee.Reid@atf.gov, or by
telephone at 202–648–9255. Written
comments and/or suggestions can also
be directed to the Office of Management
and Budget, Office of Information and
Regulatory Affairs, Attention
Department of Justice Desk Officer,
Washington, DC 20503 or sent to OIRA_
submissions@omb.eop.gov.
FOR FURTHER INFORMATION CONTACT:
Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
jbell on DSKJLSW7X2PROD with NOTICES
SUPPLEMENTARY INFORMATION:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
information to be collected can be
enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
VerDate Sep<11>2014
18:44 Dec 26, 2019
Jkt 250001
Overview of This Information
Collection
(1) Type of Information Collection:
New Collection.
(2) The Title of the Form/Collection:
Informant Agreement.
(3) The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
Form number: ATF Form 3252.2.
Component: Bureau of Alcohol,
Tobacco, Firearms and Explosives, U.S.
Department of Justice.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract:
Primary: Individuals or households.
Other: None.
Abstract: Any individual registering
as a confidential informant (CI) for ATF,
must provide their personally
identifiable information (PII) on the
Informant Agreement—(ATF Form
3252.2). ATF will utilize the
information to verify the identity of the
CI, who can provide useful and credible
information to ATF regarding felonious
criminal activities.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: An estimated 2,000
respondents will utilize the form
annually, and it will take each
respondent approximately 6 minutes to
complete the form.
(6) An estimate of the total public
burden (in hours) associated with the
collection: The estimated annual public
burden associated with this collection is
200 hours, which is equal to 2,000 (# of
respondents) * .10 (6 minutes).
If additional information is required
contact: Melody Braswell, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street NE, 3E.405A,
Washington, DC 20530.
Dated: December 20, 2019.
Melody Braswell,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2019–27924 Filed 12–26–19; 8:45 am]
BILLING CODE 4410–14–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–571]
Bulk Manufacturer of Controlled
Substances Application: Johnson
Matthey Pharmaceutical Materials Inc.
ACTION:
PO 00000
Notice of application.
Frm 00118
Fmt 4703
Sfmt 4703
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before February 25, 2020.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION:
In accordance with 21 CFR
1301.33(a), this is notice that on October
31, 2019, Johnson Matthey
Pharmaceutical Materials Inc., 25 Patton
Road, Devens, Massachusetts 01434
applied to be registered as a bulk
manufacturer of the following basic
classes of controlled substances:
DATES:
Controlled substance
Amphetamine ...........
Methylphenidate .......
Nabilone ...................
Hydrocodone ............
Levorphanol ..............
Alfentanil ...................
Remifentanil ..............
Sufentanil ..................
Drug
code
1100
1724
7379
9193
9220
9737
9739
9740
Schedule
II
II
II
II
II
II
II
II
The company plans to utilize this
facility to manufacture small quantities
of the listed controlled substances in
bulk for distribution to its customers as
well as to conduct analytical testing in
support of the company’s primary
manufacturing facility in West Deptford,
New Jersey.
Dated: December 17, 2019.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2019–27951 Filed 12–26–19; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. 17–23]
Lisa Hamilton, N.P.; Decision and
Order
On March 17, 2017, the Assistant
Administrator, Diversion Control
Division, Drug Enforcement
Administration (hereinafter,
Government), issued an Order to Show
Cause to Lisa Hamilton, N.P.,
(hereinafter, Respondent), of Taunton,1
1 According to DEA records, Respondent filed to
change her registered address during the
proceedings to 113 Washington Street, Number 1,
Foxboro, Massachusetts 02035, but the initial Order
Continued
E:\FR\FM\27DEN1.SGM
27DEN1
]]>Agencies
[Federal Register Volume 84, Number 248 (Friday, December 27, 2019)]
[Notices]
[Page 71465]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-27951]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-571]
Bulk Manufacturer of Controlled Substances Application: Johnson
Matthey Pharmaceutical Materials Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before February 25, 2020.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION:
In accordance with 21 CFR 1301.33(a), this is notice that on
October 31, 2019, Johnson Matthey Pharmaceutical Materials Inc., 25
Patton Road, Devens, Massachusetts 01434 applied to be registered as a
bulk manufacturer of the following basic classes of controlled
substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Amphetamine........................... 1100 II
Methylphenidate....................... 1724 II
Nabilone.............................. 7379 II
Hydrocodone........................... 9193 II
Levorphanol........................... 9220 II
Alfentanil............................ 9737 II
Remifentanil.......................... 9739 II
Sufentanil............................ 9740 II
------------------------------------------------------------------------
The company plans to utilize this facility to manufacture small
quantities of the listed controlled substances in bulk for distribution
to its customers as well as to conduct analytical testing in support of
the company's primary manufacturing facility in West Deptford, New
Jersey.
Dated: December 17, 2019.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2019-27951 Filed 12-26-19; 8:45 am]
BILLING CODE 4410-09-P
